Tonix Pharmaceuticals
TNXP
TNXP
13 hedge funds and large institutions have $7.23M invested in Tonix Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
13
Holders Change
+6
Holders Change %
+85.71%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
BC
1
Broadfin Capital
New York
|
$4.05M |
| 2 |
DCM
2
DAFNA Capital Management
Los Angeles,
California
|
$0 |
| 3 |
3
Barclays
London,
United Kingdom
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BC
1
Broadfin Capital
New York
| $4.05M | 392,952 | -85,048 | -18% |
|
|
RHBC
2
R.H. Bluestein & Co
Birmingham,
Michigan
| $1.85M | 179,800 | +154,800 | +619% |
|
3
Morgan Stanley
New York
| $412K | 40,000 | +5,000 | +14% |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $384K | 37,190 | +37,190 | New |
|
|
CS
5
Credit Suisse
Zurich,
Switzerland
| $200K | 19,370 | +19,370 | New |
|
|
EWM
6
Edge Wealth Management
New York
| $154K | 15,000 | +15,000 | New |
|
7
Goldman Sachs
New York
| $109K | 10,582 | +10,582 | New |
|
8
First Manhattan
New York
| $25K | 2,500 | – | – |
|
|
U
9
UBS
Zurich,
Switzerland
| $19K | 1,878 | +1,878 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $14K | 1,316 | +405 | +44% |
|
|
LTFS
11
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | 100 | +100 | New |
|
12
Bank of America
Charlotte,
North Carolina
| $1K | 106 | +106 | New |
|
13
Citigroup
New York
| $1K | 126 | +126 | New |
|
|
DCM
14
DAFNA Capital Management
Los Angeles,
California
| – | – | -45,000 | Closed |
|
|
15
Barclays
London,
United Kingdom
| – | – | -600 | Closed |
|